Remifentanil in labor | Zendy

BasavanaGouda Goudra | Zendy; Preet Mohinder Singh | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Remifentanil in labor

Author(s) -

BasavanaGouda Goudra,

Preet Mohinder Singh

Publication year - 2013

Publication title -

journal of obstetric anaesthesia and critical care

Language(s) - English

Resource type - Journals

eISSN - 2249-9539

pISSN - 2249-4472

DOI - 10.4103/2249-4472.123298

Subject(s) - remifentanil , medicine , popularity , therapeutic window , depression (economics) , intensive care medicine , suite , window (computing) , anesthesia , pharmacology , psychology , law , economics , computer science , social psychology , world wide web , political science , propofol , macroeconomics

Remifentanil is in clinical use for over 15 years. In spite of its unparalleled popularity, largely due to its unique pharmacokinetics, its place in labor analgesia is yet to be determined. Narrow therapeutic window and ability to cause rapid and severe respiratory depression are some of the major setbacks. Need for close monitoring, at least in the initial implementation stage is mandatory. Education of the labor suite nurses along with innovative monitoring technique is needed to realize the full potential of remifentanil in the labor room

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research